Evaluation of the Correlation of Calprotectin and SES-CD Score at the Time of Diagnosis and Follow-up After Diagnosis in Pediatric Patients With Crohn's Disease in Korea.
文献摘要
Background Crohn's disease (CD) requires reliable tools for monitoring intestinal inflammation. Fecal calprotectin (FC) has emerged as a promising non-invasive biomarker. This study aimed to evaluate the correlation between FC and endoscopic activity in pediatric CD confined to the colon and to establish FC cutoff values corresponding to disease severity and remission. Methods We conducted a multicenter, retrospective, cross-sectional study including 154 pediatric patients ( Results At diagnosis, the median FC was 1,355.0 mg/kg and SES-CD 14.0, with 39.6% classified as severe. At follow-up, the median FC was 126.0 mg/kg and SES-CD 2.0, with 50.7% achieving remission. FC correlated most strongly with SES-CD ( r = 0.56, P Conclusion FC strongly correlates with endoscopic activity in pediatric colonic CD, surpassing clinical indices and serum markers. The identification of clinically meaningful cutoff values may reduce the need for repeated endoscopy and support the use of FC as a surrogate marker in real-world pediatric practice.